Our investigation of 1,179 lung cancer patients showed six cases with pathogenic or likely-pathogenic germline mutations in PMS2, MSH2, or MSH6, leading to the diagnosis of Lynch syndrome in these six individuals. Here, PMS2 is linked to lung cancer.